praziquantel has been researched along with Cyst in 11 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-five patients with active neurocysticercosis were treated with praziquantel and followed for 1 year after therapy." | 7.67 | Praziquantel in the treatment of neurocysticercosis: long-term follow-up. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1985) |
| "Pharmacokinetic data of 121 individual cysts were analysed." | 6.53 | Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. ( Auer, H; Groger, M; Kaczirek, K; Lötsch, F; Naderer, J; Ramharter, M; Skuhala, T; Waneck, F, 2016) |
| " Conclusion: Praziquantel is effective and safe in the treatment of patients with neurocysticercosis." | 5.72 | Efficacy and safety of praziquantel in the treatment of neurocysticercosis in Vietnam. ( Loi, CB; Phuc, TQ; Thang, TD; Thanh, DT; Thieu, NQ; Tho, TH; Tran-Anh, L, 2022) |
| "The onset of anthelmintic treatment of neurocysticercosis (NCC) provokes an acute immune response of the host, which in human cases is associated with exacerbation of neurological symptoms." | 5.46 | Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole. ( Arroyo, G; Bustos, JA; Calcina, J; Cangalaya, C; Chacaltana, J; García, HH; Gonzalez, AE; Guerra-Giraldez, C; Mahanty, S; Mamani, J; Nash, TE; Suarez, D; Vargas-Calla, A, 2017) |
| "Cyst resolution was unsatisfactory with albendazole monotherapy but was very high when it was followed by a combination of albendazole and praziquantel." | 4.31 | Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. ( Bottieau, E; Carabin, H; Dorny, P; Fleury, A; Gabriël, S; Jackson, E; Magnussen, P; Makasi, C; Mwape, KE; Ngowi, BJ; Prazeres da Costa, C; Prodjinotho, UF; Ruether, C; Schmidt, V; Stelzle, D; Trevisan, C; Van Damme, I; Winkler, AS; Zulu, G, 2023) |
| "Thirty-five patients with active neurocysticercosis were treated with praziquantel and followed for 1 year after therapy." | 3.67 | Praziquantel in the treatment of neurocysticercosis: long-term follow-up. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1985) |
| "Pharmacokinetic data of 121 individual cysts were analysed." | 2.53 | Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. ( Auer, H; Groger, M; Kaczirek, K; Lötsch, F; Naderer, J; Ramharter, M; Skuhala, T; Waneck, F, 2016) |
| " Conclusion: Praziquantel is effective and safe in the treatment of patients with neurocysticercosis." | 1.72 | Efficacy and safety of praziquantel in the treatment of neurocysticercosis in Vietnam. ( Loi, CB; Phuc, TQ; Thang, TD; Thanh, DT; Thieu, NQ; Tho, TH; Tran-Anh, L, 2022) |
| "Management options for cystic echinococcosis (CE) remain a serious problem." | 1.48 | Management of cystic echinococcosis in the last two decades: what have we learned? ( Alonso-Sardón, M; Belhassen-García, M; Bellvis, LM; Iglesias Gomez, A; Iglesias-Iglesias, M; Jimenez Lopez, MF; Lopez-Bernus, A; Muñoz Bellido, JL; Muro, A; Pardo-Lledías, J; Romero-Alegria, A; Sampedro, JQ; Velasco-Tirado, V, 2018) |
| "The onset of anthelmintic treatment of neurocysticercosis (NCC) provokes an acute immune response of the host, which in human cases is associated with exacerbation of neurological symptoms." | 1.46 | Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole. ( Arroyo, G; Bustos, JA; Calcina, J; Cangalaya, C; Chacaltana, J; García, HH; Gonzalez, AE; Guerra-Giraldez, C; Mahanty, S; Mamani, J; Nash, TE; Suarez, D; Vargas-Calla, A, 2017) |
| "Human cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium." | 1.30 | Orbital cysticercosis. ( Lemke, BN; Sekhar, GC, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Thang, TD | 1 |
| Phuc, TQ | 1 |
| Thanh, DT | 1 |
| Thieu, NQ | 1 |
| Tho, TH | 1 |
| Loi, CB | 1 |
| Tran-Anh, L | 1 |
| Stelzle, D | 1 |
| Makasi, C | 1 |
| Schmidt, V | 1 |
| Trevisan, C | 1 |
| Van Damme, I | 1 |
| Ruether, C | 1 |
| Dorny, P | 1 |
| Magnussen, P | 1 |
| Zulu, G | 1 |
| Mwape, KE | 1 |
| Bottieau, E | 1 |
| Prazeres da Costa, C | 1 |
| Prodjinotho, UF | 1 |
| Carabin, H | 1 |
| Jackson, E | 1 |
| Fleury, A | 1 |
| Gabriël, S | 1 |
| Ngowi, BJ | 1 |
| Winkler, AS | 1 |
| Richter, J | 1 |
| Lindner, AK | 1 |
| Geisel, D | 1 |
| Torsello, GF | 1 |
| Martinez, GE | 1 |
| Isner, C | 1 |
| Schürmann, D | 1 |
| Pfäfflin, F | 1 |
| Orhun, A | 1 |
| Manciulli, T | 1 |
| Brunetti, E | 1 |
| Cangalaya, C | 1 |
| Bustos, JA | 1 |
| Calcina, J | 1 |
| Vargas-Calla, A | 1 |
| Mamani, J | 1 |
| Suarez, D | 1 |
| Arroyo, G | 1 |
| Gonzalez, AE | 1 |
| Chacaltana, J | 1 |
| Guerra-Giraldez, C | 1 |
| Mahanty, S | 1 |
| Nash, TE | 1 |
| García, HH | 2 |
| Del Brutto, OH | 2 |
| Velasco-Tirado, V | 1 |
| Romero-Alegria, A | 1 |
| Pardo-Lledías, J | 1 |
| Alonso-Sardón, M | 1 |
| Lopez-Bernus, A | 1 |
| Sampedro, JQ | 1 |
| Bellvis, LM | 1 |
| Iglesias Gomez, A | 1 |
| Muro, A | 1 |
| Muñoz Bellido, JL | 1 |
| Iglesias-Iglesias, M | 1 |
| Jimenez Lopez, MF | 1 |
| Belhassen-García, M | 1 |
| Lötsch, F | 1 |
| Naderer, J | 1 |
| Skuhala, T | 1 |
| Groger, M | 1 |
| Auer, H | 1 |
| Kaczirek, K | 1 |
| Waneck, F | 1 |
| Ramharter, M | 1 |
| Sekhar, GC | 1 |
| Lemke, BN | 1 |
| Parker, F | 1 |
| Hladky, JP | 1 |
| Breton, JO | 1 |
| Mignard, C | 1 |
| Laporte, JP | 1 |
| Bousquet, C | 1 |
| Barinagarrementeria, F | 1 |
| Sotelo, J | 1 |
| Torres, B | 1 |
| Rubio-Donnadieu, F | 1 |
| Escobedo, F | 1 |
| Rodriguez-Carbajal, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characteristics of Patients With Symptomatic Active Neurocysticercosis and Effect of Treatment on Symptoms, Lesions and Quality of Life in Resource-poor Rural Areas of Eastern Africa - TOPANA, a Multi-centre Prospective Cohort Study.[NCT03834337] | 63 participants (Actual) | Observational | 2019-04-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for praziquantel and Cyst
| Article | Year |
|---|---|
Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Topics: Albendazole; Anticestodal Agents; Antiparasitic Agents; Brain; Cysts; Epilepsy; Female; Humans; Infl | 2017 |
Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Topics: Albendazole; Animals; Anthelmintics; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Praziqu | 2016 |
9 other studies available for praziquantel and Cyst
| Article | Year |
|---|---|
Efficacy and safety of praziquantel in the treatment of neurocysticercosis in Vietnam.
Topics: Alanine Transaminase; Albendazole; Anthelmintics; Anticonvulsants; Antiparasitic Agents; Aspartate A | 2022 |
Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.
Topics: Albendazole; Anthelmintics; Antiparasitic Agents; Cysts; Humans; Neurocysticercosis; Praziquantel; P | 2023 |
Treatment of a giant hepatic echinococcal cyst with percutaneous drainage and in vivo assessment of the protoscolicidal effect of praziquantel.
Topics: Animals; Cysts; Drainage; Echinococcosis, Hepatic; Echinococcus; Humans; Praziquantel | 2021 |
Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
Topics: Albendazole; Animals; Anthelmintics; Brain; Cysts; Disease Models, Animal; Drug Therapy, Combination | 2017 |
Management of cystic echinococcosis in the last two decades: what have we learned?
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Clinical Protocols; Combined Mo | 2018 |
Orbital cysticercosis.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Conjunctiva; Conjun | 1997 |
[Racemous cysticercosis of the cauda equina and cystic arachnoiditis. Apropos of 2 cases].
Topics: Adult; Arachnoiditis; Cauda Equina; Cysticercosis; Cysts; Female; Humans; Laminectomy; Male; Middle | 1988 |
Ataxic hemiparesis from parenchymal brain cysticercosis.
Topics: Adult; Brain Diseases; Cysts; Female; Hemiplegia; Humans; Praziquantel | 1988 |
Praziquantel in the treatment of neurocysticercosis: long-term follow-up.
Topics: Adolescent; Adult; Arachnoiditis; Brain Diseases; Cerebrospinal Fluid Proteins; Cysticercosis; Cysts | 1985 |